Policy & Regulation

This project examined current collaborations between housing providers and health care providers. Recent delivery system reforms have provided new or expanded opportunities at the state, local, and organizational level to forge collaborations between health care and housing providers.

ABSTRACT

Department of Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson have issued a proposed rule, “Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in

This project brought together policymakers, practitioners and evaluators in October 2017 to identify key policy research questions in the child support program.  The discussions, coupled with a series of informant interviews from 2016, led to the development of the research agenda.  It is a framework for the broader child support community to collectively answer pressing policy questi

ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.

Many people with behavioral health disorders receive suboptimal care and suffer poor health outcomes, including premature death. States, health plans, providers, and other stakeholders need a strong set of measures targeting this population to improve the quality of their care.

This project developed methods and measures that can be used to quantify the public benefits that result from Interoperable Health Information Exchange (IEHI). In the first phase of this project, a literature review was conducted and discussions were held with subject matter experts to identify areas where evidence suggests that the greatest benefits resulting from IEHI might be found.

Summary

The U.S. Department of Health and Human Services (HHS) is required to assess the benefits and costs of its major regulations prior to promulgation. To support these assessments, in 2016 HHS issued its Guidelines for Regulatory Impact Analyses, developed under the leadership of its Office of the Assistant Secretary for Planning and Evaluation and its Department-wide Analytics Team.

This ASPE Data Point analyzes premium increases from two data series, comparing premium costs in individual market plans purchased by consumers in 2013 to exchange plans purchased in 2017 in order to better determine how much premiums have increased since the ACA’s key provisions have taken effect.